California Can Now Inspect Your Out-of-State Pharmacy at Renewal. Here Is What They Will Ask For.

By: Mark Boesen, Pharm.D., J.D.
mboesen@bslawusa.com | 480/687-2628 (mobile)

If you hold a California nonresident pharmacy permit and you ship into the state, the rules of the road changed on July 1, 2026. That is the operative date for the nonresident provisions of AB 1503, the pharmacy bill Governor Newsom signed on October 1, 2025. The headline for most operators is the new California-licensed pharmacist-in-charge requirement. The provision that will actually cost you money and sleep, though, is the one that gets less attention: the California State Board of Pharmacy now has explicit authority to inspect your out-of-state pharmacy in connection with licensure and renewal, and to bill you for the privilege.

We are already seeing renewal inspection notices go out. If you have not built an inspection-readiness file, now is the time.

What AB 1503 Actually Did

AB 1503 amended Business and Professions Code section 4112, the statute that governs nonresident pharmacies. Three pieces matter here.

First, inspection authority. The Board may inspect a nonresident pharmacy, generally on a periodic cycle of roughly every four years, and more frequently if something about the pharmacy's practices raises a concern. This is no longer a gray area or a courtesy arrangement built on your home-state report. It is a statutory power.

Second, cost recovery. Under BPC section 4112(k), the Board can recover the full reasonable cost of inspecting you, travel included. The mechanics are worth understanding because they have teeth. When an inspection is required, the Board notifies you of an estimated cost and requires a deposit up front. After the inspection, the Board invoices you for any balance. And here is the part that should get your attention: the Board will not act on your renewal until the deposit and the final invoice are paid in full. Miss the deposit or sit on the invoice and your renewal stalls, no matter how clean your operation is.

Third, the California PIC. As a condition of registering and of ongoing licensure, a nonresident pharmacy must now identify a California-licensed pharmacist, employed and actually working at the site, to serve as PIC over its California operations. A pharmacist licensed only in your home state no longer qualifies for that role.

For sterile compounders shipping into California, none of this replaces the separate nonresident sterile compounding license regime under Article 7.5 and BPC sections 4127.1 through 4127.4, which already carries a physical Board inspection of the out-of-state facility and periodic inspection thereafter. AB 1503 layers a broader, statutorily grounded inspection and cost-recovery structure on top of a world that sterile compounders already knew was inspection-heavy.

What a Renewal Inspection Notice Looks Like in Practice

The abstract statutory authority becomes very concrete the moment an assigned inspector emails you a document request with a hard deadline. We recently reviewed a sterile renewal inspection notice sent to a nonresident sterile compounding permit holder that gave the pharmacy about nine days to produce a full electronic package. That is not a lot of runway if you are assembling it from scratch.

The request is a good map of exactly what California cares about. If you can produce all of it quickly and cleanly, you are in good shape. If any category makes you wince, that is your project list. Here is what a sterile renewal inspection package is being built around right now.

Self-assessments and staff. Your most recent completed self-assessment for both compounding and community pharmacy, with a current staff roster and license numbers. Remember that AB 1503 also tightened the self-assessment cadence: every odd-numbered year and within 30 days of certain licensing, location, or PIC changes. A stale or missing self-assessment is an easy, avoidable finding.

Facility and equipment changes. A written description of any change to the physical layout of the sterile compounding suite or to sterile compounding equipment over the past 12 months, with pictures or drawings where a change occurred.

Product scope. A description of any change in the types of sterile products you compound, including category changes and any move between non-hazardous and hazardous, plus a full list of the sterile medications and their categories compounded in the past 12 months.

Policies and procedures. Every new or updated sterile compounding policy and procedure from the past 12 months, along with documentation that the PIC completed the annual review of your P&Ps. If your PIC has not signed off on that annual review, do it before the notice arrives, not after.

Outside inspections. Any FDA, DEA, or accreditation inspection from the past 12 months, the resulting reports, and your responses. The Board wants to see not just that you were inspected, but how you closed the loop.

Certification and environmental data. Your most recent certification records for all ISO-classified areas, including viable sampling reports with remediation where applicable, and smoke pattern (airflow visualization) videos for every ISO 5 space. These are frequently the hardest items to produce on short notice, so confirm your certifier's records are current and retrievable.

Monitoring logs. Cleaning logs for the past two months, with the cleaning, disinfecting, and sporicidal agents identified; refrigerator, freezer, incubator, and room temperature logs for two months; pressure differential logs for two months; and equipment calibration and maintenance logs for two months. Two months of logs sounds trivial until you find a gap.

Quality and safety data. Qualitative and quantitative analysis results for CSPs over the past 12 months, and any adverse drug reactions tied to your CSPs in that window.

Representative documentation. Compounding worksheets, master formulas, and labels for two CSPs, chosen to show your process end to end.

Competencies. Personnel competency records for compounding staff, typically one pharmacist and one technician, covering didactic training, pharmaceutical calculations, gloved fingertip sampling, media fill testing, and hands-on aseptic technique, cleaning, and garbing.

Waivers and prior report. Any pharmacy law waivers currently in use, and a copy of last year's inspection report for the same license.

The Takeaway

Two things follow from all of this, and they point in the same direction.

The compliance substance is not new to a well-run sterile compounder. USP 797 already expects nearly everything on that list. What is new is that California can now compel you to hand it over on a compressed timeline, as a gate on your renewal, and can make you pay for the visit. The risk is less that you are non-compliant and more that you cannot prove compliance fast enough when the notice lands.

So treat the inspection-readiness file as a standing asset, not a fire drill. Keep the self-assessments current, the PIC's annual P&P review signed and dated, the certification and viable sampling records retrievable, the logs continuous with no gaps, and the competency files complete for the staff most likely to be pulled as examples. Build an internal process for the money side too: who authorizes the estimated-cost deposit, who tracks the post-inspection invoice, and who confirms payment so a renewal never gets held up over an unpaid balance.

And confirm your California PIC situation now if you have not. A pharmacy that nails every document on the list but cannot name a California-licensed, on-site PIC has a different and more fundamental problem.

If your renewal is coming up and you want a second set of eyes on the package before it goes to the inspector, that is exactly the kind of work we do. Better to find the gap on our timeline than on theirs.

This article is provided by Boesen & Snow Law for general informational purposes and does not constitute legal advice or create an attorney-client relationship. Consult qualified counsel regarding your specific circumstances.